StockData
Adagio Medical Holdings, Inc. logo

Adagio Medical Holdings, Inc. (ADGM) shareholders

ADGMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 2/30
$1.65+0.04 (+2.48%)

Close on Nov 17, 2026Market cap $1.37MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
67.9%
15M of 22M shares
Institutional holders
24
4 new, 3 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
2 buys · 0 sales
Net bought $243.97K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Perceptive Advisors LLC
Joint filing with Joseph Edelman (55.40%), Perceptive Life Sciences Master Fund, Ltd. (54.70%)
15,321,65555.40%13G (passive) amendmentMar 31, 2026
Joseph Edelman
Joint filing with Perceptive Advisors LLC (57.50%), Perceptive Life Sciences Master Fund, Ltd. (56.80%)
15,321,65557.50%13G (passive) amendmentDec 31, 2025
Alyeska Fund GP, LLC
Joint filing with Alyeska Investment Group, L.P. (9.90%), Anand Parekh (9.90%)
2,096,7849.90%13G (passive)Dec 31, 2025
Peter Kolchinsky
Joint filing with RA Capital Management, L.P. (9.90%), Rajeev Shah (9.90%) and 1 more
1,613,2209.90%13G (passive) amendmentDec 31, 2024
Phillip Gross
Joint filing with Adage Capital Management, L.P. (5.67%), Robert Atchinson (5.67%)
1,258,5015.67%13G (passive) amendmentMar 31, 2026
Daniel Schneeberger
Joint filing with ADAR1 Capital Management, LLC (5.40%)
1,205,4475.40%13G (passive) amendmentJun 30, 2026
ADAR1 Capital Management, LLC
Joint filing with Daniel Schneeberger (5.70%)
1,205,4475.70%13G (passive)Dec 31, 2025
Rajeev Shah
Joint filing with RA Capital Management, L.P. (7.20%), Peter Kolchinsky (7.20%) and 1 more
1,200,0007.20%13G (passive) amendmentJun 30, 2025
RA Capital Management, L.P.
Joint filing with Peter Kolchinsky (7.20%), Rajeev Shah (7.20%) and 1 more
1,200,0007.20%13G (passive) amendmentMar 31, 2025
Adage Capital Management, L.P.
Joint filing with Robert Atchinson (6.88%), Phillip Gross (6.88%)
1,058,5016.88%13G (passive) amendmentSep 30, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ADGMValueChange% of portfolio
Perceptive Advisors LLC9,876,58644.47%$6.44M+100.10%
Adage Capital Partners Gp, L.L.C.1,258,5015.67%$820.04K–0.00%
ADAR1 Capital Management, LLC1,205,4475.43%$785.47K–0.04%
Alyeska Investment Group, L.P.1,159,6155.22%$755.61K–0.00%
Sio Capital Management, LLC698,9893.15%$455.46K−589,4720.08%
Silverarc Capital Management, LLC224,3601.01%$146.19K−27,6120.02%
Shaolin Capital Management LLC171,1700.77%$111.53K–0.01%
Vanguard Capital Management LLC108,9540.49%$71.04K+69,3460.00%
Affinity Asset Advisors, LLC80,0000.36%$52.13K–0.00%
Geode Capital Management, LLC79,1150.36%$51.55K−46,1260.00%
Vanguard Fiduciary Trust Co53,7820.24%$35.07K–0.00%
Northern Trust Corp30,8750.14%$20.12K+9,2770.00%
Toronto Dominion Bank25,0000.11%$16.30K–0.00%
Opaleye Management Inc.18,4440.08%$13.35K–0.00%
XTX Topco Ltd18,1530.08%$11.83K−5,1970.00%
Citadel Advisors LLC16,1550.07%$10.53KNew0.00%
Hrt Financial LP13,7050.06%$8.00KNew0.00%
Citigroup Inc13,2550.06%$8.64K+13,2540.00%
Bank Of America Corp /De/11,5310.05%$7.51K−1,3260.00%
Tower Research Capital LLC (TRC)6,4540.03%$4.21K+4,2520.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20262415M67.9%4 / 55 / 30M1M
Q1 20262316M70.5%6 / 42 / 30M1M
Q4 20252117M74.5%11 / 52 / 55M0M
Q3 20251512M52.4%4 / 14 / 10M1M
Q2 20251212M53.4%1 / 63 / 41M0M
Q1 20251512M52.2%3 / 42 / 31M0M
Q4 20241511M48.6%5 / 42 / 20M1M
Q3 20241212M54.1%12 / 00 / 012M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

5 funds held ADGM in Q2 2026, 57% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of ADGMValue% of fundAs of
Vanguard Extended Market Index Fund91,5120.41%$59.63K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund66,9690.30%$48.49K0.00%May 31, 2026
Vanguard Total Stock Market Index Fund17,4420.08%$11.37K0.00%Jun 30, 2026
Fidelity Series Total Market Index Fund10,4000.05%$7.53K0.00%May 31, 2026
Fidelity Nasdaq Composite Index Fund5,4360.02%$3.94K0.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Todd UsenChief Executive Officer, Director207,3150.93%Mar 9, 2026
Deborah KasterChief Financial Officer15,0000.07%Mar 9, 2026
Dan GeorgeInterim CFO––Apr 28, 2025
Keyvan Mirsaeedi-FarahaniDirector12,7700.06%Oct 13, 2026
Sandra A. GardinerDirector––Aug 12, 2026
Orly MishanDirector––Aug 12, 2026
Sean SalmonDirector––Aug 12, 2026
James L. CoxDirector36,6980.17%Aug 12, 2026
Timothy P. MoranDirector––Aug 12, 2026
Advisors Llc PerceptiveDirector, 10% owner9,876,58644.47%Oct 22, 2025
Life Sciences LLC C2Director, 10% owner––Feb 14, 2025
Life Sciences Master Fund Ltd Perceptive10% owner––Oct 22, 2025
Joseph Edelman10% owner––Oct 22, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Deborah Kaster
Chief Financial Officer
Dec 16, 2025Buy+15,000$1.20$18.00K15,000
Todd Usen
Chief Executive Officer, Director
Dec 12, 2025Buy+207,315$1.09$225.97K207,315
Advisors Llc Perceptive
Director, 10% owner
Jan 22, 2025Award+64,167––9,675,684
Keyvan Mirsaeedi-Farahani
Director
Sep 27, 2024Other+12,770––12,770
Adam Leo Stone
10% owner
Sep 27, 2024Other−3,501,600––0
James L. Cox
Director
Jul 31, 2024Other+36,698––36,698
Hakon Bergheim
Chief Operating Officer
Jul 31, 2024Other+7,539––7,539
Olav Bergheim
CEO, Director
Jul 31, 2024Other+22,081––22,081
Olav Bergheim
CEO, Director
Jul 31, 2024Other+212,053––212,053

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
17.50%
0M shares short
Days to cover
1.0
At 1M shares a day
Change since last report
+17.1%
From 0M shares
Short volume, 20 days
37.2%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Adagio Medical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,802,007 shares on Sep 24, 2026 over the last 90 days.

See a number that looks wrong?